Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Head-to-head trial demonstrates Viramune®’s similar efficacy and more favourable effect on lipid profile compared to atazanavir/ritonavir
Boehringer Ingelheim, 09/17/09
Results from the ARTEN* trial presented at the 5th International AIDS Society conference in Cape Town, South Africa demonstrated non–inferiority regarding efficacy between Viramune and ritonavir boosted atazanavir both combined with tenofovir and emtricitabine. This head–to–head study also showed Viramune's more favourable effect on the lipid profile and now clearly confirms the combination's place as an important first line therapy for patients with HIV.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


